Curarisation prolongée après mivacurium chez une patiente traitée par cyclophosphamide

Whittaker, 1980, Plasma cholinesterase variants and the anaesthetist, Anaesthesia, 35, 174, 10.1111/j.1365-2044.1980.tb03800.x Lepage, 1985, Total cholinesterase in plasma : biological variations and reference limits, Clin Chem, 31, 546, 10.1093/clinchem/31.4.546 Jensen, 1991, Significance of plasma cholinesterase for the anaesthetist, Curr Anaesth Crit Care, 2, 232, 10.1016/S0953-7112(05)80151-6 Dilmann, 1987, Safe use of succinylcholine during repeated anesthetics in a patient treated with cyclophosphamide, Anesth Analg, 66, 351 Diefenbach, 1992, Mivacurium : dose-response relationship and administration by repeated injection or infusion, Anesth Analg, 74, 420, 10.1213/00000539-199203000-00018 Cook, 1992, Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure, Br J Anaesth, 69, 580, 10.1093/bja/69.6.580 Devlin, 1993, Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis, Br J Anaesth, 71, 227, 10.1093/bja/71.2.227 Bevan, 1993, Prolonged mivacurium-induced neuromuscular block [editorial], Anesth Analg, 77, 4, 10.1213/00000539-199307000-00002 Cook, 1989, In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine, Anesth Analg, 68, 452, 10.1213/00000539-198904000-00005